Ernexa Therapeutics, Inc. (ERNA)

0.1962 -0.01 (-5.58%) USD  |  NASDAQ  |  Apr 20, 11:09
More

Ernexa Therapeutics SG&A Expense (Quarterly) : 1.418M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for ERNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Ocular Therapeutix, Inc. 30.62M
Quince Therapeutics, Inc. 3.635M
Recursion Pharmaceuticals, Inc. 33.66M
Tango Therapeutics, Inc. 9.763M
Aprea Therapeutics, Inc. 1.638M